Gilmore Neil O'Neill is a director of Unity Biotechnology Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Editas Medicine, Inc.
6 Jun 24
144
Editas Medicine, Inc.
31 May 24
4
Editas Medicine, Inc.
5 Mar 24
144
Editas Medicine, Inc.
4 Mar 24
4
Unity Biotechnology, Inc.
26 Jun 23
4
Editas Medicine, Inc.
7 Jun 23
144
Editas Medicine, Inc.
2 Jun 23
4
Editas Medicine, Inc.
6 Mar 23
4
Unity Biotechnology, Inc.
27 Jun 22
4
Editas Medicine, Inc.
6 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Jun 24 | EDIT Editas Medicine | Common Stock | Sell | Dispose S | No | No | 5.4956 | 12,191 | 67.00 k | 315,279 |
5 Mar 24 | EDIT Editas Medicine | Common Stock | Sell | Dispose S | No | No | 9.4172 | 77,824 | 732.88 k | 327,470 |
2 Mar 24 | EDIT Editas Medicine | Common Stock | Grant | Acquire A | No | No | 0 | 72,212 | 0.00 | 405,294 |
2 Mar 24 | EDIT Editas Medicine | Common Stock | Grant | Acquire A | No | No | 0 | 72,213 | 0.00 | 333,082 |
2 Mar 24 | EDIT Editas Medicine | Common Stock | Grant | Acquire A | No | No | 0 | 130,700 | 0.00 | 260,869 |
2 Mar 24 | EDIT Editas Medicine | Stock Option (right to buy) Common Stock | Grant | Acquire A | No | No | 10.53 | 392,100 | 4.13 mm | 392,100 |
23 Jun 23 | UBX Unity Biotechnology | Stock Option Common Stock | Grant | Acquire A | No | No | 3.25 | 6,000 | 19.50 k | 6,000 |
5 Jun 23 | EDIT Editas Medicine | Common Stock | Sell | Dispose S | No | No | 9.5032 | 6,486 | 61.64 k | 130,169 |
2 Mar 23 | EDIT Editas Medicine | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 136,655 |
2 Mar 23 | EDIT Editas Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 8.72 | 150,000 | 1.31 mm | 150,000 |